122 related articles for article (PubMed ID: 33848777)
1. Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma.
Rasmussen JH; Olin AB; Lelkaitis G; Hansen AE; Andersen FL; Johannesen HH; Kjaer A; Fischer BM; Specht L; Bentzen SM; von Buchwald C; Wessel I; Vogelius IR
Eur J Radiol; 2021 Jun; 139():109668. PubMed ID: 33848777
[TBL] [Abstract][Full Text] [Related]
2. Does multiparametric imaging with
Rasmussen JH; Olin A; Lelkaitis G; Hansen AE; Andersen FL; Johannesen HH; Kjær A; Vogelius IR; Specht L; Bentzen SM; Wessel I; von Buchwald C; Fischer BM
Br J Cancer; 2020 Jul; 123(1):46-53. PubMed ID: 32382113
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma.
Rasmussen GB; Vogelius IR; Rasmussen JH; Schumaker L; Ioffe O; Cullen K; Fischer BM; Therkildsen MH; Specht L; Bentzen SM
Acta Oncol; 2015; 54(9):1408-15. PubMed ID: 26256482
[TBL] [Abstract][Full Text] [Related]
4. Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in
Chen RY; Lin YC; Shen WC; Hsieh TC; Yen KY; Chen SW; Kao CH
Sci Rep; 2018 Jan; 8(1):105. PubMed ID: 29311707
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H
BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331
[TBL] [Abstract][Full Text] [Related]
6. Associations Between [
Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET cannot predict expression of clinically relevant histopathological biomarkers in head and neck squamous cell carcinoma: a meta-analysis.
Surov A; Pech M; Eckert A; Arens C; Grosser O; Wienke A
Acta Radiol; 2022 Feb; 63(2):166-175. PubMed ID: 33541089
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
[TBL] [Abstract][Full Text] [Related]
9. Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
Yan A; Hanna A; Wilson TG; Deraniyagala R; Krauss DJ; Grzywacz VP; Yan D; Wilson GD
Radiother Oncol; 2021 Nov; 164():196-201. PubMed ID: 34619238
[TBL] [Abstract][Full Text] [Related]
10. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
[TBL] [Abstract][Full Text] [Related]
13. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
14. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
15. The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
Baschnagel AM; Wobb JL; Dilworth JT; Williams L; Eskandari M; Wu D; Pruetz BL; Wilson GD
Radiother Oncol; 2015 Oct; 117(1):118-24. PubMed ID: 26328941
[TBL] [Abstract][Full Text] [Related]
16. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
Martens RM; Noij DP; Ali M; Koopman T; Marcus JT; Vergeer MR; de Vet H; de Jong MC; Leemans CR; Hoekstra OS; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Oral Oncol; 2019 Jan; 88():75-83. PubMed ID: 30616800
[TBL] [Abstract][Full Text] [Related]
17. Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.
Choi JW; Lee D; Hyun SH; Han M; Kim JH; Lee SJ
Clin Radiol; 2017 Jun; 72(6):482-489. PubMed ID: 28285707
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of
Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
[No Abstract] [Full Text] [Related]
19. Comparison of diffusion-weighted MR imaging and
Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
[TBL] [Abstract][Full Text] [Related]
20. Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
Bittner MI; Wiedenmann N; Bucher S; Hentschel M; Mix M; Rücker G; Weber WA; Meyer PT; Werner M; Grosu AL; Kayser G
Acta Oncol; 2016 Nov; 55(11):1299-1304. PubMed ID: 27593107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
